Lozy’s Pharmaceuticals

What Lozy’s Pharmaceuticals does

Lozy's Pharmaceuticals, S.L. is a privately held Contract Development and Manufacturing Organization (CDMO) based in Lekaroz, Navarra, Spain, specializing in pharmaceutical lozenges (hard-boiled candies). The company operates a state-of-the-art single-purpose manufacturing facility compliant with European health regulations (EU MDR), producing both sugar and sugar-free lozenge formulations across various shapes and flavors, packaged in blister or pocket-pack presentations. Its core technology includes an electronic excipient weighing and feeding system integrated with a controlled cooking process, supporting precise formulation control across multiple active pharmaceutical ingredients (APIs) primarily for the cough, sore throat, and cold therapeutic categories.

The business model is exclusively B2B enterprise field sales: Lozy's engages directly with pharmaceutical companies seeking to outsource lozenge development, formulation, regulatory support, manufacturing, and packaging, building long-term contractual CDMO partnerships. Revenue is generated through professional services contracts scoped by formulation complexity, volume, and service scope; pricing is not publicly disclosed. The company is a member of QUBE group, a diversified conglomerate that provides corporate governance and group infrastructure. Its sole disclosed leadership figure is co-founder Alejandro Alonso, and headcount is reported at 11-50 employees.

Lozy's has received multiple regional public grants from the Gobierno de Navarra and the European Regional Development Fund (ERDF) between 2018 and 2025 for industrial SME investment, digital transformation, and competitiveness improvement, which have funded facility expansion and digitization initiatives. No external venture funding, acquisitions, or public listing have been disclosed. The company serves primarily the European pharmaceutical market with global CDMO sales reach via direct enterprise engagement, though no named customer relationships, revenue figures, or product launches beyond the existing lozenge portfolio have been publicly documented.

Name

Lozy’s Pharmaceuticals

Legal name

LOZY'S PHARMACEUTICALS, S.L.

Website

https://lozyspharma.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Lozy's Pharmaceuticals is a Spain-based CDMO that develops, manufactures, and packages pharmaceutical lozenges (sugar and sugar-free) for third-party pharmaceutical companies, operating a dedicated EU-compliant facility under the QUBE group umbrella.

Ownership category

akta.pro rank

Product category

Pharmaceutical CDMO (Contract Manufacturing)

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Contract pharmaceutical manufacturing
• Pharmaceutical lozenge production
• CDMO services
• Pharmaceutical formulation development
• Pharmaceutical packaging services

Headquarters

HQ city

Lecároz

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

1. Contract Manufacturing Services (CDMO): Full-service pharmaceutical development and contract manufacturing for third parties, including innovation, R&D, regulatory support, formulation, manufacturing and packaging of pharmaceutical lozenges. Revenue generated through long-term contractual partnerships with pharmaceutical companies requiring outsourcing of lozenge production.
2. Pharmaceutical Development Services: Technical feasibility analysis, innovative formulation development, and release of commercial batches. Services include regulatory support, providing integrated seamless approach to reliable and efficient outsourcing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Lozy's Pharmaceuticals is a Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and packages pharmaceutical lozenges (hard-boiled candies) for third-party pharmaceutical companies. The portfolio covers sugar and sugar-free formulations for the cough, sore throat, cold category and custom APIs, delivered in blister or pocket pack presentations. Services span the full lifecycle from technical feasibility analysis, R&D, regulatory support, and formulation through commercial batch manufacturing and packaging under European health regulatory compliance.

Product overview

Lozy's Pharmaceuticals is a CDMO (Contract Development and Manufacturing Organization) that offers a unified portfolio of pharmaceutical lozenge products and services. The core product line consists of sugar-free and sugar-containing hard-boiled candy lozenges available in various shapes and flavours, targeting the cough/sore throat/cold category and custom APIs. These products are offered in two packaging formats: blister packs and pocket packs. The service portfolio complements the product line through integrated pharmaceutical development (innovation, R&D, regulatory support, formulation) and contract manufacturing services (commercial batch production and packaging), providing customers with a seamless from-feasibility-to-commercialization outsourcing solution.

Differentiator

Problem solved

Functional benefit

Products and services

• Sugar-Containing Pharmaceutical Lozenges Traditional pharmaceutical hard-boiled candy lozenges with a sugar base, formulated for cough, sore throat, cold category, and custom APIs, available in different shapes and flavors with blister and pocket pack packaging options. Targeted at third-party pharmaceutical companies served via the CDMO model.
• Sugar-Free Pharmaceutical Lozenges Pharmaceutical hard-boiled candy lozenges manufactured without sugar content, designed for various active pharmaceutical ingredients (APIs). Available in different shapes and flavors with blister and pocket pack packaging options, targeted at pharmaceutical companies requiring sugar-free formulations.
• Pharmaceutical Development Services Full-service pharmaceutical development for lozenge products including innovation, R&D, regulatory support, and formulation services. Provides a seamless, integrated approach to outsourcing, serving pharmaceutical companies seeking to bring new lozenge formulations to market.
• Contract Manufacturing (CDMO) Services Contract development and manufacturing organization services for pharmaceutical lozenges, including commercial batch production, manufacturing, and packaging operations, in compliance with European health regulations. Delivered as long-term contractual partnerships with pharmaceutical companies requiring outsourced lozenge production.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• QUBE GroupcoreStrategic or Co-development PartnerLozy's Pharmaceuticals is privately owned and operates as part of the QUBE group. The company follows an ethical code that governs the conduct and activities of executives, employees and government bodies. An Internal Information System (whistleblower channel) has been implemented as part of the QUBE group to report any contrary or irregular conduct.

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Broad incumbents

• Catalent: Large global CDMO offering softgel, oral solid dose, and specialty formulations. Comparable as a broad incumbent competing for the same pharmaceutical outsourcing wallet, though Catalent spans many more dosage forms than Lozy's.
• Hovione: Portuguese CDMO with integrated drug substance and drug product services, including oral solid dose capabilities. Comparable as a European-based CDMO serving similar pharma outsourcing customers.
• Recipharm: Swedish-headquartered CDMO with extensive solid dose manufacturing across Europe. Comparable as a broad European CDMO competitor offering similar contract manufacturing services to pharma clients.
• NextPharma: European CDMO offering solid, semi-solid, and sterile dosage forms. Comparable as a regional European CDMO incumbent serving similar pharmaceutical outsourcing customers across multiple dose formats.
• Aenova: One of Europe's largest pharmaceutical contract manufacturers, with broad solid and semi-solid dose capabilities. Comparable as a larger European CDMO incumbent that could compete for lozenge and solid oral contracts.
• Alcami Corporation: US-based CDMO offering oral solid dose and sterile manufacturing services. Comparable as a mid-sized CDMO competing for similar contract manufacturing and pharmaceutical development engagements.

Direct peers

• Adare Pharma Solutions: US-headquartered specialty CDMO with strong capabilities in oral dose forms, taste-masking, and patient-friendly dosage formats including orally disintegrating and lozenge-style products—overlapping with Lozy's CDMO service profile.
• Hermes Pharma: German CDMO specializing in oral dosage forms including lozenges, effervescent tablets, and chewables. Closest comparable to Lozy's given the shared focus on user-friendly solid oral dosage formats for third-party pharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lozy’s Pharmaceuticals